Guy Zeltser
Chief Financial Officer
Replay available
Hippo Holdings Inc. (NYSE: HIPO) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Chief Financial Officer
President and Chief Executive Officer
Director of Corporate Communications
Analyst, Jefferies
Analyst, B. Riley
Hello, everyone, and a warm welcome to the HIPPO Q2 2025 earnings call. My name is Emily, and I'll be coordinating your call today. After the presentation, you will have the opportunity to ask any questions, which you can do so by pressing Start, followed by the number 1 on your telephone keypad. I would now like to turn the call over to Mark Olson, Director of Corporate Communications, to begin. Please go ahead. Thank you, operator. Good morning and thank you for joining HIPPO's 2025 Second Quarter Earnings Call. Earlier today, HIPPO issued a shareholder letter announcing its Q2 2025 results, which is available at investors.hippo.com. Leading today's discussion will be HIPPO President and Chief Executive Officer Rick McCatherin and Chief Financial Officer Guy Zelzer. Following management's prepared remarks, we will open up the call to questions. Before we begin, we'd like to remind you that our discussion will contain predictions, expectations, forward-looking statements, and other information about our business that are based on management's current expectations as of the date of this presentation. Forward-looking statements include, but are not limited to, IFO's expectations or predictions of financial and business performance and conditions and competitive and industry outlook. Forward-looking statements are subject to risk uncertainties, and other factors that could cause our actual results to differ materially from our historical results and or from our forecast, including those set forth in HIPAA's Form 10-Q filed today. For more information, please refer to the risks, uncertainties, and other factors discussed in HIPAA's SEC filings, in particular in the section entitled Risk Factors in our Form 10-Q. All cautionary statements are applicable to any forward-lo...